Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Organovo (ONVO)

Organovo Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONVO
DateTimeSourceHeadlineSymbolCompany
22/11/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
20/11/202413:05GlobeNewswire Inc.Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver MeetingNASDAQ:ONVOOrganovo Holdings Inc
14/11/202420:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONVOOrganovo Holdings Inc
13/11/202413:06GlobeNewswire Inc.Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver DiseasesNASDAQ:ONVOOrganovo Holdings Inc
08/11/202421:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
25/10/202421:00Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ONVOOrganovo Holdings Inc
18/09/202420:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ONVOOrganovo Holdings Inc
09/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
09/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
09/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
09/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
09/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
07/08/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
05/08/202420:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
26/07/202420:05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ONVOOrganovo Holdings Inc
24/07/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
16/07/202412:05GlobeNewswire Inc.Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative ColitisNASDAQ:ONVOOrganovo Holdings Inc
31/05/202420:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ONVOOrganovo Holdings Inc
21/05/202412:05GlobeNewswire Inc.Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel DiseaseNASDAQ:ONVOOrganovo Holdings Inc
14/05/202416:45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
14/05/202415:00GlobeNewswire Inc.Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)NASDAQ:ONVOOrganovo Holdings Inc
13/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
10/05/202421:15Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
09/05/202400:00GlobeNewswire Inc.Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public OfferingNASDAQ:ONVOOrganovo Holdings Inc
15/04/202412:05GlobeNewswire Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboNASDAQ:ONVOOrganovo Holdings Inc
09/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONVOOrganovo Holdings Inc
08/02/202421:56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
08/02/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
07/02/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
26/01/202422:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONVOOrganovo Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ONVO